Terms: = Pancreatic cancer AND ERG, P11308, 2078 AND Treatment
8 results:
1. The Usefulness of Elastin Staining to Detect Vascular Invasion in cancer.
Gonzalez J; Bahmad HF; Ocejo S; Abreu A; Popp M; Gogola S; Fernandez V; Recine M; Poppiti R
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894944
[TBL] [Abstract] [Full Text] [Related]
2. Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or stable after olaparib treatment.
Fumet JD; Limagne E; Thibaudin M; Truntzer C; Bertaut A; Rederstorff E; Ghiringhelli F
BMC Cancer; 2020 Aug; 20(1):748. PubMed ID: 32778095
[TBL] [Abstract] [Full Text] [Related]
3. Comparison of erg and SPINK1 expression among incidental and metastatic prostate cancer in Japanese men.
Koide H; Kimura T; Inaba H; Sato S; Iwatani K; Yorozu T; Furusato B; Kamata Y; Miki J; Kiyota H; Takahashi H; Egawa S
Prostate; 2019 Jan; 79(1):3-8. PubMed ID: 30051483
[TBL] [Abstract] [Full Text] [Related]
4. Paclitaxel as Albumin-Bound Nanoparticles with Gemcitabine for Untreated Metastatic pancreatic cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Stainthorpe A; Greenhalgh J; Bagust A; Richardson M; Boland A; Beale S; Duarte R; Kotas E; Banks L; Palmer D
Pharmacoeconomics; 2018 Oct; 36(10):1153-1163. PubMed ID: 29600384
[TBL] [Abstract] [Full Text] [Related]
5. Pegylated Liposomal Irinotecan Hydrochloride Trihydrate for Treating pancreatic cancer After Gemcitabine: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Fleeman N; Abdulla A; Bagust A; Beale S; Richardson M; Stainthorpe A; Boland A; Kotas E; McEntee J; Palmer D
Pharmacoeconomics; 2018 Mar; 36(3):289-299. PubMed ID: 29178025
[TBL] [Abstract] [Full Text] [Related]
6. Molecular Discriminators of Racial Disparities in Prostate cancer.
Ateeq B; Bhatia V; Goel S
Trends Cancer; 2016 Mar; 2(3):116-120. PubMed ID: 28741531
[TBL] [Abstract] [Full Text] [Related]
7. The spectrum of neuroendocrine tumors: histologic classification, unique features and areas of overlap.
Klimstra DS; Beltran H; Lilenbaum R; Bergsland E
Am Soc Clin Oncol Educ Book; 2015; ():92-103. PubMed ID: 25993147
[TBL] [Abstract] [Full Text] [Related]
8. Phase II study of cytarabine in men with docetaxel-refractory, castration-resistant prostate cancer with evaluation of TMPRSS2-erg and SPINK1 as serum biomarkers.
Dhani NC; Emmenegger U; Adams L; Jongstra J; Tannock IF; Sridhar SS; Knox JJ; Day JR; Groskopf J; Joshua AM
BJU Int; 2012 Sep; 110(6):840-5. PubMed ID: 22313860
[TBL] [Abstract] [Full Text] [Related]
